BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7511332)

  • 1. Expression of the thrombospondin receptor (CD36) on the cell surface in megakaryoblastic and promegakaryocytic leukemias: increment of the receptor by megakaryocyte differentiation in vitro.
    Imamura N; Ota H; Abe K; Kuramoto A
    Am J Hematol; 1994 Feb; 45(2):181-4. PubMed ID: 7511332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of peroxidase negative acute leukemias by monoclonal antibodies--II. Acute megakaryoblastic and acute pro-megakaryocytic leukemias.
    Imamura N; Kajihara H; Kuramoto A
    Leuk Res; 1988; 12(4):279-89. PubMed ID: 3163741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different expression of CD36 antigen molecule on the surface of megakaryocyte lineage leukemias and megakaryocyte leukemia cell lines MEG-01 and HEL.
    Imamura N; Mtasiwa DM; Inada T; Kuramoto A
    Leukemia; 1990 Jul; 4(7):525-8. PubMed ID: 1695706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varied expressions of receptors on the human megakaryoblastic cell line MEG-01 by monoclonal antibodies.
    Imamura N; Mtasiwa DM; Inada T; Kuramoto A; Ogura M; Saito H
    Am J Hematol; 1990 Jun; 34(2):154-6. PubMed ID: 2339681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of megakaryocytic differentiation in a newly established human leukemic cell line by 12-o-tetradecanoylphorbol-13-acetate.
    Chiu CF; Lin CK; Liu SM; Tan TD; Chau WK; Lin FM
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):1-11. PubMed ID: 7553404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
    Zipursky A; Christensen H; De Harven E
    Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocytic leukemia and platelet factor 4.
    Ryo R; Yasunaga M; Saigo K; Yamaguchi N
    Leuk Lymphoma; 1992 Nov; 8(4-5):327-36. PubMed ID: 1337850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines.
    Imamura N; Mtasiwa DM; Ota H; Inada T; Kuramoto A
    Am J Hematol; 1990 Sep; 35(1):65-7. PubMed ID: 2389771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of intracellular CD41 antigen detection to the diagnosis of acute megakaryoblastic leukemia].
    Miki J; Koike K; Sawai N; Matsuura H; Kurokawa Y; Sakashita K; Nakazawa T; Ito S; Hidaka E; Koike T; Komiyama A
    Rinsho Ketsueki; 1999 Jul; 40(7):568-73. PubMed ID: 10483140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein I identification during normal and pathological megakaryocytic maturation.
    Breton-Gorius J; Vanhaeke D; Tabilio A; Vainchenker W; Deschamps JF; Xu FS
    Blood Cells; 1983; 9(2):275-91. PubMed ID: 6229299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.
    Takeuchi S; Sugito S; Uemura Y; Miyagi T; Kubonishi I; Taguchi H; Enzan H; Ohtsuki Y; Miyoshi I
    Leukemia; 1992 Jun; 6(6):588-94. PubMed ID: 1602796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human interferons in inducing differentiation of acute megakaryoblastic leukaemia blast cells.
    Hassan HT; Grell S; Borrmann-Danso U; Freund M
    Leuk Lymphoma; 1995 Jan; 16(3-4):329-33. PubMed ID: 7536511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular expression of CD61 precedes surface expression.
    Käfer G; Willer A; Ludwig W; Krämer A; Hehlmann R; Hastka J
    Ann Hematol; 1999 Oct; 78(10):472-4. PubMed ID: 10550559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
    San Miguel JF; Gonzalez M; Cañizo MC; Ojeda E; Orfao A; Caballero MD; Moro MJ; Fisac P; Lopez Borrasca A
    Blood; 1988 Aug; 72(2):402-7. PubMed ID: 3165292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of a cell line established from a case of acute megakaryoblastic leukemia.
    Skinnider LF; Pabello P; Zheng CY
    Acta Haematol; 1997; 98(1):26-31. PubMed ID: 9210910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia.
    Breton-Gorius J; Villeval JL; Kieffer N; Mitjavila MT; Guichard J; Vainchenker W
    Blood Cells; 1989; 15(1):259-77. PubMed ID: 2649184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.